Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/1999
05/27/1999WO1999025830A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999WO1999025829A2 Cdk2 protein and cdk2 protein complexes
05/27/1999WO1999025828A1 A human 2-19 protein homologue, z219c
05/27/1999WO1999025827A1 Neuralized protein, polynucleotide encoding the same, and antibody recognizing the same
05/27/1999WO1999025825A2 EXTENDED cDNAs FOR SECRETED PROTEINS
05/27/1999WO1999025818A1 Method of identifying binding site domains that retain the capacity of binding to an epitope
05/27/1999WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof
05/27/1999WO1999025735A1 Chimeric pre-activated transcription factors
05/27/1999WO1999025734A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS
05/27/1999WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
05/27/1999WO1999013908A9 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
05/27/1999WO1999012964A3 Kay - a novel immune system protein
05/27/1999WO1999006553B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES
05/27/1999CA2320399A1 A human 2-19 protein homologue, z219c
05/27/1999CA2310631A1 High molecular weight .gamma.-poly(glutamic acid)
05/27/1999CA2310624A1 Chimeric pre-activated transcription factors
05/27/1999CA2309761A1 Th2 cell depletion; compositions; methods
05/27/1999CA2309390A1 Cdk2 protein and cdk2 protein complexes
05/27/1999CA2309343A1 Toso
05/27/1999CA2309339A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999CA2309336A1 Neuralized protein, polynucleotide encoding the same, and antibody recognizing the same
05/27/1999CA2308571A1 Single-chain bifunctional glycoprotein hormones
05/27/1999CA2308365A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999CA2302644A1 Extended cdnas for secreted proteins
05/26/1999EP0917584A1 Modified tomato mottle geminivirus coat protein gene
05/26/1999EP0917581A1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
05/26/1999EP0917577A2 Herpes simplex virus icp4 is an inhibitor of apoptosis
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917571A1 Agouti-related gene
05/26/1999EP0917539A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
05/26/1999EP0917538A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
05/26/1999EP0917428A1 Hybrid matrix implants and explants
05/26/1999EP0833835A4 Obesity protein intermediates and their preparation and use
05/26/1999EP0668910B1 Human neuropeptide y-y1 receptor
05/26/1999EP0616641B1 Humanized b-b10, an anti-il2 receptor antibody
05/26/1999EP0589993B1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
05/26/1999EP0453560B1 Localization and characterization of the wilms' tumor gene
05/26/1999CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
05/26/1999CN1217748A Transferrin receptor genes of moraxella
05/26/1999CN1217632A Method of protein production using mitochondrial translation system
05/26/1999CN1217342A Colony stimulating factor for recombination of human granulocytes and medicinal composition thereof
05/26/1999CN1217339A Cellulose binding domain
05/26/1999CN1217335A Method for preparing precursor medicine
05/25/1999US5907038 Azepanes
05/25/1999US5907034 With same affinity to ethylenediamine tetraacetic acid and diethylenetriamine pentaacetic acid as to their complexes with manganese, cadmium, zinc, copper, yttrium, or lead
05/25/1999US5907033 Anti-oncostatin M monoclonal antibodies
05/25/1999US5907016 Method of coupling ligands onto supports and products produced therefrom
05/25/1999US5906939 Cultured fibroblast or epithelial cell dissociation method using sulfated polysaccharide and chelator
05/25/1999US5906938 Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor
05/25/1999US5906923 ATPase inhibitor
05/25/1999US5906821 Viral nucleotide sequences
05/25/1999US5906820 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
05/25/1999CA1340557C Ckmb assay and monoclonal antibodies for use in same
05/25/1999CA1340555C Oral vaccines
05/20/1999WO1999024836A1 125 human secreted proteins
05/20/1999WO1999024613A1 Human blood bacterium
05/20/1999WO1999024601A1 Secreted protein nsl4
05/20/1999WO1999024599A1 Enzymatically catalysed n-acylation of amino acids, protein hydrolyzates and/or derivatives thereof
05/20/1999WO1999024598A1 Enzymatically catalysed n-acylation of amino acids, protein hydrolyzates and/or derivatives thereof
05/20/1999WO1999024595A1 The translation enhancer element of the human amyloid precursor protein gene
05/20/1999WO1999024583A1 Dna demethylase, therapeutic and diagnostic uses thereof
05/20/1999WO1999024582A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999WO1999024579A1 Novel era
05/20/1999WO1999024576A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999WO1999024567A1 Tissue cement proteins from rhipicephalus appendiculatus
05/20/1999WO1999024562A1 Method of increasing efficiency of directed evolution of a gene using phagemid
05/20/1999WO1999024559A2 Nuclear targeting by means of streptococcal protein h
05/20/1999WO1999024472A2 Glycosylated antibodies and antibody fragments having reactive ketone groups
05/20/1999WO1999024466A2 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
05/20/1999WO1999024455A1 Detection systems for registering protein interactions and functional relationships
05/20/1999WO1999024069A1 Preventives and remedies for diffuse lung diseases
05/20/1999WO1999023867A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999010494A3 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
05/20/1999WO1999009182A3 Rab proteins
05/20/1999WO1999007736A3 Lipoprotein-regulating medicaments
05/20/1999WO1999006549B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
05/20/1999WO1999004007A9 Increasing production of proteins in gram-positive microorganisms
05/20/1999WO1998051788A3 Method and construct for inhibition of cell migration
05/20/1999CA2310213A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999CA2309640A1 Nuclear targeting by means of bacterial proteins
05/20/1999CA2309598A1 Preventives and remedies for diffuse lung disease
05/20/1999CA2309559A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999CA2309535A1 The translation enhancer element of the human amyloid precursor protein gene
05/20/1999CA2309360A1 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999CA2309320A1 Glycosylated antibodies and antibody fragments having reactive ketone groups
05/20/1999CA2309207A1 Method of increasing efficiency of directed evolution of a gene using phagemid
05/20/1999CA2308779A1 Human blood bacterium
05/20/1999CA2308768A1 125 human secreted proteins
05/20/1999CA2308440A1 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use
05/20/1999CA2305847A1 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
05/19/1999EP0916732A1 The engineering of electronic interactions at metal ion binding sites for the stabilization of proteins
05/19/1999EP0916727A2 Novel LysS
05/19/1999EP0916680A2 Lantibiotic related to Actagardine, process of preparation and use thereof
05/19/1999EP0916678A2 Method of clotting blood
05/19/1999EP0915987A2 POLY-($g(a)-L-ASPARTIC ACID), POLY-($g(a)-L-GLUTAMIC ACID) AND COPOLYMERS OF L-ASP AND L-GLU, METHOD FOR THEIR PRODUCTION AND THEIR USE
05/19/1999EP0915977A1 B. burgdorferi polypeptides expressed in vivo
05/19/1999EP0915974A1 Modified tie-2-receptor ligands
1 ... 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 ... 1125